Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

UDP-Glucuronosyltransferase (UGT) 2B15 Pharmacogenetics: UGT2B15 D85Y Genotype and Gender Are Major Determinants of Oxazepam Glucuronidation by Human Liver

Michael H. Court, Qin Hao, Soundararajan Krishnaswamy, Tanios Bekaii-Saab, Abdul Al-Rohaimi, Lisa L. von Moltke and David J. Greenblatt
Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 656-665; DOI: https://doi.org/10.1124/jpet.104.067660
Michael H. Court
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qin Hao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soundararajan Krishnaswamy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanios Bekaii-Saab
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdul Al-Rohaimi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa L. von Moltke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Greenblatt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 310 no. 2 656-665
DOI 
https://doi.org/10.1124/jpet.104.067660
PubMed 
15044558

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received February 26, 2004
  • Accepted March 25, 2004
  • Published online July 16, 2004.

Article Versions

  • Earlier version (March 25, 2004 - 12:47).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Michael H. Court,
  2. Qin Hao,
  3. Soundararajan Krishnaswamy,
  4. Tanios Bekaii-Saab1,
  5. Abdul Al-Rohaimi,
  6. Lisa L. von Moltke and
  7. David J. Greenblatt
  1. Comparative and Molecular Pharmacogenetics Laboratory (M.H.C., Q.H., S.K., A.A.R.) and Clinical Pharmacology Laboratory (T.B.S., L.L.v.M., D.J.G.), Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, Massachusetts
  1. Address correspondence to:
    Dr. Michael H. Court, Comparative and Molecular Pharmacogenetics Laboratory, Department of Pharmacology and Experimental Therapeutics, Tufts University, 136 Harrison Ave., Boston, MA 02111. E-mail: michael.court{at}tufts.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: March 2004 to May 2022

AbstractFullPdf
Mar 200414011
Apr 200450037
May 200448032
Jun 200467041
Jul 20041777092
Aug 200414610371
Sep 2004758135
Oct 2004834019
Nov 2004894616
Dec 2004663238
Jan 2005633025
Feb 2005343839
Mar 2005314815
Apr 2005124015
May 2005173818
Jun 2005144013
Jul 200520456
Aug 2005104019
Sep 200592527
Oct 2005103118
Nov 2005104417
Dec 200563216
Jan 200654019
Feb 2006123217
Mar 200673015
Apr 200672018
May 200632317
Jun 200621612
Jul 200662217
Aug 200652817
Sep 200641618
Oct 200671214
Nov 2006172815
Dec 2006102514
Jan 2007102315
Feb 200771715
Mar 2007102821
Apr 2007152320
May 200792114
Jun 200731511
Jul 200781310
Aug 200751212
Sep 200751619
Oct 200752422
Nov 200741310
Dec 20071115
Jan 2008102223
Feb 200871513
Mar 200851611
Apr 200891120
May 200861512
Jun 2008162916
Jul 200892015
Aug 2008112713
Sep 2008322418
Oct 2008231811
Nov 200816167
Dec 200852517
Jan 20096338
Feb 200963813
Mar 200915158
Apr 200952416
May 200941413
Jun 20094125
Jul 20094139
Aug 200941715
Sep 2009111810
Oct 20091258
Nov 20091179
Dec 20091022
Jan 20106130
Feb 20105131
Mar 201012211
Apr 20101090
May 201013190
Jun 201026172
Jul 201017201
Aug 20107160
Sep 201011280
Oct 201012453
Nov 20107232
Dec 201010242
Jan 20119312
Feb 20118311
Mar 20115435
Apr 201116440
May 201172610
Jun 2011201817
Jul 201162515
Aug 201171623
Sep 2011103521
Oct 2011114926
Nov 201183427
Dec 2011132019
Jan 201293224
Feb 201273616
Mar 2012163625
Apr 201282818
May 2012123211
Jun 2012111810
Jul 201293122
Aug 201233019
Sep 201294613
Oct 201282725
Nov 2012114420
Dec 2012111119
Jan 2013101313
Feb 201361720
Mar 2013132122
Apr 201362527
May 201371727
Jun 201371620
Jul 201321310
Aug 201302113
Sep 201351510
Oct 20138147
Nov 20133119
Dec 20130117
Jan 201491310
Feb 2014112017
Mar 20144126
Apr 2014131811
May 201442316
Jun 201452316
Jul 2014212915
Aug 201441216
Sep 201491526
Oct 201471813
Nov 201441511
Dec 2014186
Jan 2015559
Feb 201510510
Mar 20155117
Apr 20156183
May 20156207
Jun 20151155
Jul 20155911
Aug 20153184
Sep 201510185
Oct 20157168
Nov 20157145
Dec 2015142011
Jan 2016161611
Feb 201683924
Mar 2016413324
Apr 2016443416
May 201621516
Jun 2016121918
Jul 201682018
Aug 201682711
Sep 2016101711
Oct 201634420
Nov 20166409
Dec 201603610
Jan 201713710
Feb 20173265
Mar 20170276
Apr 20174225
May 20173156
Jun 20173227
Jul 201732011
Aug 201721410
Sep 201712312
Oct 201761914
Nov 201724713
Dec 201712911
Jan 201841311
Feb 20185309
Mar 201831787
Apr 201822328
May 201811226
Jun 201834515
Jul 201813811
Aug 20181606
Sep 201813814
Oct 201823318
Nov 201816026
Dec 20184386
Jan 20194437
Feb 20193023
Mar 20193622
Apr 20192854
May 201918617
Jun 2019907
Jul 20191913
Aug 20193623
Sep 20192224
Oct 20192226
Nov 20193213
Dec 20192679
Jan 20202421
Feb 20202197
Mar 20201100
Apr 20202321
May 20202322
Jun 20201612
Jul 20201110
Aug 20201211
Sep 20202024
Oct 2020711
Nov 20201441
Dec 20202023
Jan 202129203
Feb 202112142
Mar 20212343
Apr 20213312
May 20212481
Jun 2021691
Jul 20211212
Aug 202121135
Sep 20212692
Oct 20212140
Nov 20212342
Dec 20213362
Jan 20224238
Feb 20222722
Mar 20222131
Apr 20224437
May 20221003

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 310 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 310, Issue 2
1 Aug 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
UDP-Glucuronosyltransferase (UGT) 2B15 Pharmacogenetics: UGT2B15 D85Y Genotype and Gender Are Major Determinants of Oxazepam Glucuronidation by Human Liver
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

UDP-Glucuronosyltransferase (UGT) 2B15 Pharmacogenetics: UGT2B15 D85Y Genotype and Gender Are Major Determinants of Oxazepam Glucuronidation by Human Liver

Michael H. Court, Qin Hao, Soundararajan Krishnaswamy, Tanios Bekaii-Saab, Abdul Al-Rohaimi, Lisa L. von Moltke and David J. Greenblatt
Journal of Pharmacology and Experimental Therapeutics August 1, 2004, 310 (2) 656-665; DOI: https://doi.org/10.1124/jpet.104.067660

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

UDP-Glucuronosyltransferase (UGT) 2B15 Pharmacogenetics: UGT2B15 D85Y Genotype and Gender Are Major Determinants of Oxazepam Glucuronidation by Human Liver

Michael H. Court, Qin Hao, Soundararajan Krishnaswamy, Tanios Bekaii-Saab, Abdul Al-Rohaimi, Lisa L. von Moltke and David J. Greenblatt
Journal of Pharmacology and Experimental Therapeutics August 1, 2004, 310 (2) 656-665; DOI: https://doi.org/10.1124/jpet.104.067660
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Transport Is Not Rate-Limiting in Morphine Glucuronidation in the Single-Pass Perfused Rat Liver Preparation
  • Enhanced Hepatic Uptake and Bioactivity of Type α1(I) Collagen Gene Promoter-Specific Triplex-Forming Oligonucleotides after Conjugation with Cholesterol
  • Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana
Show more ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics